Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Dalbavancin Use in the Emergency Department Setting.

Patel M, Smalley S, Dubrovskaya Y, Siegfried J, Caspers C, Pham V, Press RA, Papadopoulos J.

Ann Pharmacother. 2019 Jun 3:1060028019855159. doi: 10.1177/1060028019855159. [Epub ahead of print]

PMID:
31155916
2.

Evaluation of Pharmacy-Developed Antibiotic Desensitization Protocols.

Chen XJC, Fong K, Altshuler D, Dubrovskaya Y, Louie E, Amoroso N, Goldenberg R, Papadopoulos J.

Ann Pharmacother. 2019 Mar;53(3):229-251. doi: 10.1177/1060028018801959. Epub 2018 Sep 20.

PMID:
30234369
3.

Evaluation of Meropenem Extended Versus Intermittent Infusion Dosing Protocol in Critically Ill Patients.

Ahmed N, Jen SP, Altshuler D, Papadopoulos J, Pham VP, Dubrovskaya Y.

J Intensive Care Med. 2018 Jan 1:885066618784264. doi: 10.1177/0885066618784264. [Epub ahead of print]

PMID:
29954243
4.

Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen.

Okoduwa A, Ahmed N, Guo Y, Scipione MR, Papadopoulos J, Eiras DP, Dubrovskaya Y.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00025-18. doi: 10.1128/AAC.00025-18. Print 2018 Aug.

5.

Multilayer Model of Pharmacy Participation in the Antimicrobial Stewardship Program at a Large Academic Medical Center.

Dubrovskaya Y, Scipione MR, Siegfried J, Jen SP, Pham V, Papadopoulos J, Decano A, Lewis T, Dabestani A.

Hosp Pharm. 2017 Oct;52(9):628-634. doi: 10.1177/0018578717726993. Epub 2017 Aug 29.

6.

Population Pharmacokinetics of Polymyxin B.

Manchandani P, Thamlikitkul V, Dubrovskaya Y, Babic JT, Lye DC, Lee LS, Tam VH.

Clin Pharmacol Ther. 2018 Sep;104(3):534-538. doi: 10.1002/cpt.981. Epub 2018 Jan 8.

PMID:
29238962
7.

Invasive Nontyphoidal Salmonella Infection in a Patient with Early-Stage Chronic Lymphocytic Leukemia.

Slawek D, Dubrovskaya Y, Louie E.

Case Rep Infect Dis. 2017;2017:9091276. doi: 10.1155/2017/9091276. Epub 2017 Oct 29.

8.

Tigecycline as a Second-Line Agent for Legionnaires' Disease in Severely Ill Patients.

Slawek D, Altshuler D, Dubrovskaya Y, Louie E.

Open Forum Infect Dis. 2017 Oct 7;4(4):ofx184. doi: 10.1093/ofid/ofx184. eCollection 2017 Fall.

9.

Implementing an Inpatient Pediatric Prospective Audit and Feedback Antimicrobial Stewardship Program Within a Larger Medical Center.

Lighter-Fisher J, Desai S, Stachel A, Pham VP, Klejmont L, Dubrovskaya Y.

Hosp Pediatr. 2017 Sep;7(9):516-522. doi: 10.1542/hpeds.2016-0144. Epub 2017 Aug 16.

10.

Role of postgraduate year 2 pharmacy residents in providing weekend antimicrobial stewardship coverage in an academic medical center.

Siegfried J, Merchan C, Scipione MR, Papadopoulos J, Dabestani A, Dubrovskaya Y.

Am J Health Syst Pharm. 2017 Mar 15;74(6):417-423. doi: 10.2146/ajhp160133.

PMID:
28274985
11.

Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.

Mousavi M, Zapolskaya T, Scipione MR, Louie E, Papadopoulos J, Dubrovskaya Y.

Pharmacotherapy. 2017 Mar;37(3):379-385. doi: 10.1002/phar.1901. Epub 2017 Feb 17.

PMID:
28079263
12.

Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes.

Kontsevaya I, Nikolayevskyy V, Kovalyov A, Ignatyeva O, Sadykhova A, Simak T, Tikhonova O, Dubrovskaya Y, Vasiliauskiene E, Davidaviciene E, Skenders G, Makurina O, Balabanova Y, Drobniewski F.

Infect Genet Evol. 2017 Mar;48:76-82. doi: 10.1016/j.meegid.2016.12.016. Epub 2016 Dec 18.

13.

Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.

Thamlikitkul V, Dubrovskaya Y, Manchandani P, Ngamprasertchai T, Boonyasiri A, Babic JT, Tam VH.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01337-16. doi: 10.1128/AAC.01337-16. Print 2017 Jan.

14.

Comparative Pharmacokinetic Profiling of Different Polymyxin B Components.

Manchandani P, Dubrovskaya Y, Gao S, Tam VH.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6980-6982. doi: 10.1128/AAC.00702-16. Print 2016 Nov.

15.

Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge.

Merchan C, Parajuli S, Siegfried J, Scipione MR, Dubrovskaya Y, Rahimian J.

Case Rep Infect Dis. 2016;2016:3607125. doi: 10.1155/2016/3607125. Epub 2016 Jun 23.

16.

Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients.

Solodokin LJ, Klejmont LM, Scipione MR, Dubrovskaya Y, Lighter-Fisher J, Papadopoulos J.

J Pediatr Hematol Oncol. 2016 Aug;38(6):e180-5. doi: 10.1097/MPH.0000000000000584.

PMID:
27164533
17.

Single high dose gentamicin for perioperative prophylaxis in orthopedic surgery: Evaluation of nephrotoxicity.

Dubrovskaya Y, Tejada R, Bosco J 3rd, Stachel A, Chen D, Feng M, Rosenberg A, Phillips M.

SAGE Open Med. 2015 Oct 28;3:2050312115612803. doi: 10.1177/2050312115612803. eCollection 2015.

18.

Allergic Reactions in Hospitalized Patients With a Self-Reported Penicillin Allergy Who Receive a Cephalosporin or Meropenem.

Crotty DJ, Chen XJ, Scipione MR, Dubrovskaya Y, Louie E, Ladapo JA, Papadopoulos J.

J Pharm Pract. 2017 Feb;30(1):42-48. doi: 10.1177/0897190015587254. Epub 2016 Jul 9.

PMID:
26038245
19.

Risk factors for nephrotoxicity onset associated with polymyxin B therapy.

Dubrovskaya Y, Prasad N, Lee Y, Esaian D, Figueroa DA, Tam VH.

J Antimicrob Chemother. 2015;70(6):1903-7. doi: 10.1093/jac/dkv014. Epub 2015 Feb 3.

PMID:
25652747
20.

Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.

Penziner S, Dubrovskaya Y, Press R, Safdar A.

Antimicrob Agents Chemother. 2015 Mar;59(3):1776-81. doi: 10.1128/AAC.04268-14. Epub 2014 Dec 22.

21.

Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease.

Nikolayevskyy V, Miotto P, Pimkina E, Balabanova Y, Kontsevaya I, Ignatyeva O, Ambrosi A, Skenders G, Ambrozaitis A, Kovalyov A, Sadykhova A, Simak T, Kritsky A, Mironova S, Tikhonova O, Dubrovskaya Y, Rodionova Y, Cirillo D, Drobniewski F.

Tuberculosis (Edinb). 2015 Mar;95(2):179-85. doi: 10.1016/j.tube.2014.11.005. Epub 2014 Dec 9.

PMID:
25534168
22.

The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA.

Catanzano A, Phillips M, Dubrovskaya Y, Hutzler L, Bosco J 3rd.

Iowa Orthop J. 2014;34:111-7.

23.

Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients.

Brumer E, Dubrovskaya Y, Scipione MR, Aberle C, Rahimian J, Papadopoulos J.

J Pharm Pract. 2015 Dec;28(6):511-7. doi: 10.1177/0897190014544817. Epub 2014 Aug 11.

PMID:
25112304
24.

Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.

Cutro SR, Holzman R, Dubrovskaya Y, Chen XJ, Ahuja T, Scipione MR, Chen D, Papadopoulos J, Phillips MS, Mehta SA.

Antimicrob Agents Chemother. 2014 Aug;58(8):4470-5. doi: 10.1128/AAC.02759-14. Epub 2014 May 27.

25.

Orthopedic surgical site infections: analysis of causative bacteria and implications for antibiotic stewardship.

Norton TD, Skeete F, Dubrovskaya Y, Phillips MS, Bosco JD 3rd, Mehta SA.

Am J Orthop (Belle Mead NJ). 2014 May;43(5):E89-92.

PMID:
24839634
26.

Structure, enzymatic transformation and anticancer activity of branched high molecular weight laminaran from brown alga Eisenia bicyclis.

Menshova RV, Ermakova SP, Anastyuk SD, Isakov VV, Dubrovskaya YV, Kusaykin MI, Um BH, Zvyagintseva TN.

Carbohydr Polym. 2014 Jan;99:101-9. doi: 10.1016/j.carbpol.2013.08.037. Epub 2013 Aug 21.

PMID:
24274485
27.

Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.

Wang YL, Scipione MR, Dubrovskaya Y, Papadopoulos J.

Antimicrob Agents Chemother. 2014;58(1):176-82. doi: 10.1128/AAC.01324-13. Epub 2013 Oct 21.

28.

Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.

Dubrovskaya Y, Chen TY, Scipione MR, Esaian D, Phillips MS, Papadopoulos J, Mehta SA.

Antimicrob Agents Chemother. 2013 Nov;57(11):5394-7. doi: 10.1128/AAC.00510-13. Epub 2013 Aug 19.

29.

Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.

Clutter DS, Dubrovskaya Y, Merl MY, Teperman L, Press R, Safdar A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4501-5. doi: 10.1128/AAC.01120-13. Epub 2013 Jul 8.

30.

Antibiotic stewardship for intra-abdominal infections: early impact on antimicrobial use and patient outcomes.

Dubrovskaya Y, Papadopoulos J, Scipione MR, Altshuler J, Phillips M, Mehta SA.

Infect Control Hosp Epidemiol. 2012 Apr;33(4):427-9. doi: 10.1086/664765. No abstract available.

PMID:
22418644
31.

Effectiveness and tolerability of a polymyxin B dosing protocol.

Esaian D, Dubrovskaya Y, Phillips M, Papadopoulos J.

Ann Pharmacother. 2012 Mar;46(3):455-6. doi: 10.1345/aph.1Q294. Epub 2012 Mar 6. No abstract available.

PMID:
22395248

Supplemental Content

Loading ...
Support Center